A citation-based method for searching scientific literature


List of co-cited articles
360 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The glutamate homeostasis hypothesis of addiction.
Peter W Kalivas. Nat Rev Neurosci 2009
863
33

Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography.
Funda Akkus, Simon M Ametamey, Valerie Treyer, Cyrill Burger, Anass Johayem, Daniel Umbricht, Baltazar Gomez Mancilla, Judit Sovago, Alfred Buck, Gregor Hasler. Proc Natl Acad Sci U S A 2013
75
30

Metabotropic glutamate receptors: physiology, pharmacology, and disease.
Colleen M Niswender, P Jeffrey Conn. Annu Rev Pharmacol Toxicol 2010
25

Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice.
C Chiamulera, M P Epping-Jordan, A Zocchi, C Marcon, C Cottiny, S Tacconi, M Corsi, F Orzi, F Conquet. Nat Neurosci 2001
435
25

Association of Long-Term Nicotine Abstinence With Normal Metabotropic Glutamate Receptor-5 Binding.
Funda Akkus, Valerie Treyer, Anass Johayem, Simon M Ametamey, Baltazar Gomez Mancilla, Judit Sovago, Alfred Buck, Gregor Hasler. Biol Psychiatry 2016
26
34

Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy.
Diana Martinez, Mark Slifstein, Nabeel Nabulsi, Alexander Grassetti, Nina B L Urban, Audrey Perez, Fei Liu, Shu-Fei Lin, Jim Ropchan, Xiangling Mao,[...]. Biol Psychiatry 2014
47
22

Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking.
Vidhya Kumaresan, Menglu Yuan, Judy Yee, Katie R Famous, Sharon M Anderson, Heath D Schmidt, R Christopher Pierce. Behav Brain Res 2009
127
19

Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans.
L M Hulka, V Treyer, M Scheidegger, K H Preller, M Vonmoos, M R Baumgartner, A Johayem, S M Ametamey, A Buck, E Seifritz,[...]. Mol Psychiatry 2014
37
19

mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior.
Pia Bäckström, Daniel Bachteler, Sabrina Koch, Petri Hyytiä, Rainer Spanagel. Neuropsychopharmacology 2004
208
19

Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Jorge A Quiroz, Paul Tamburri, Dennis Deptula, Ludger Banken, Ulrich Beyer, Michael Rabbia, Nikhat Parkar, Paulo Fontoura, Luca Santarelli. JAMA Psychiatry 2016
84
19


Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats.
Joyce Besheer, Sara Faccidomo, Julie J M Grondin, Clyde W Hodge. Alcohol Clin Exp Res 2008
80
19

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.
F Gasparini, K Lingenhöhl, N Stoehr, P J Flor, M Heinrich, I Vranesic, M Biollaz, H Allgeier, R Heckendorn, S Urwyler,[...]. Neuropharmacology 1999
649
16

Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.
M S Milella, L Marengo, K Larcher, A Fotros, A Dagher, P Rosa-Neto, C Benkelfat, M Leyton. Neuroimage 2014
39
16

The role of ventral and dorsal striatum mGluR5 in relapse to cocaine-seeking and extinction learning.
Lori A Knackstedt, Heather L Trantham-Davidson, Marek Schwendt. Addict Biol 2014
54
16

mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats.
Justin T Gass, Megan P H Osborne, Noreen L Watson, Jordan L Brown, M Foster Olive. Neuropsychopharmacology 2009
101
16

A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.
Thomas M Keck, Mu-Fa Zou, Guo-Hua Bi, Hai-Ying Zhang, Xiao-Fei Wang, Hong-Ju Yang, Ratika Srivastava, Eliot L Gardner, Zheng-Xiong Xi, Amy Hauck Newman. Addict Biol 2014
28
21

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
François Tison, Charlotte Keywood, Mark Wakefield, Franck Durif, Jean-Christophe Corvol, Karla Eggert, Mark Lew, Stuart Isaacson, Erwan Bezard, Sonia-Maria Poli,[...]. Mov Disord 2016
88
16

18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry.
Dean F Wong, Rikki Waterhouse, Hiroto Kuwabara, Jongho Kim, James R Brašić, Wichana Chamroonrat, Michael Stabins, Daniel P Holt, Robert F Dannals, Terence G Hamill,[...]. J Nucl Med 2013
77
16

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
P Jeffrey Conn, Arthur Christopoulos, Craig W Lindsley. Nat Rev Drug Discov 2009
789
16


Neurobiology of addiction: a neurocircuitry analysis.
George F Koob, Nora D Volkow. Lancet Psychiatry 2016
16

mGluR5 receptors in the basolateral amygdala and nucleus accumbens regulate cue-induced reinstatement of ethanol-seeking behavior.
Courtney M Sinclair, Richard M Cleva, Lauren E Hood, M Foster Olive, Justin T Gass. Pharmacol Biochem Behav 2012
75
16

Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder.
Funda Akkus, Yoan Mihov, Valerie Treyer, Simon M Ametamey, Anass Johayem, Smeralda Senn, Susanne Rösner, Alfred Buck, Gregor Hasler. Transl Psychiatry 2018
27
22

Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.
Andreea S Pop, Baltazar Gomez-Mancilla, Giovanni Neri, Rob Willemsen, Fabrizio Gasparini. Psychopharmacology (Berl) 2014
67
13

The neural basis of addiction: a pathology of motivation and choice.
Peter W Kalivas, Nora D Volkow. Am J Psychiatry 2005
13


Partial mGlu₅ Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects.
Robert W Gould, Russell J Amato, Michael Bubser, Max E Joffe, Michael T Nedelcovych, Analisa D Thompson, Hilary H Nickols, Johannes P Yuh, Xiaoyan Zhan, Andrew S Felts,[...]. Neuropsychopharmacology 2016
28
17

The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.
Clyde W Hodge, Michael F Miles, Amanda C Sharko, Rebekah A Stevenson, Jennie R Hillmann, Veronique Lepoutre, Joyce Besheer, Jason P Schroeder. Psychopharmacology (Berl) 2006
119
13

VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy.
Hilary Highfield Nickols, Joannes P Yuh, Karen J Gregory, Ryan D Morrison, Brittney S Bates, Shaun R Stauffer, Kyle A Emmitte, Michael Bubser, Weimin Peng, Michael T Nedelcovych,[...]. J Pharmacol Exp Ther 2016
27
18


Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
Simon M Ametamey, Lea J Kessler, Michael Honer, Matthias T Wyss, Alfred Buck, Samuel Hintermann, Yves P Auberson, Fabrizio Gasparini, Pius A Schubiger. J Nucl Med 2006
142
13

Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.
Simon M Ametamey, Valerie Treyer, Johannes Streffer, Matthias T Wyss, Mark Schmidt, Milen Blagoev, Samuel Hintermann, Yves Auberson, Fabrizio Gasparini, Uta C Fischer,[...]. J Nucl Med 2007
133
13

Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases.
Georg Jaeschke, Sabine Kolczewski, Will Spooren, Eric Vieira, Nadia Bitter-Stoll, Patrick Boissin, Edilio Borroni, Bernd Büttelmann, Simona Ceccarelli, Nicole Clemann,[...]. J Med Chem 2015
43
13

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
Elizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, Sébastien Jacquemont, Perrine Charles, Jeannie Visootsak, Marc Brinkman, Karin Rerat, Barbara Koumaras, Liansheng Zhu,[...]. Sci Transl Med 2016
163
13

Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias.
Olivier Rascol, Susan Fox, Fabrizio Gasparini, Christopher Kenney, Thérèse Di Paolo, Baltazar Gomez-Mancilla. Parkinsonism Relat Disord 2014
80
13

Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.
Richard H P Porter, Georg Jaeschke, Will Spooren, Theresa M Ballard, Bernd Büttelmann, Sabine Kolczewski, Jens-Uwe Peters, Eric Prinssen, Jürgen Wichmann, Eric Vieira,[...]. J Pharmacol Exp Ther 2005
235
13

Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
Lothar Lindemann, Richard H Porter, Sebastian H Scharf, Basil Kuennecke, Andreas Bruns, Markus von Kienlin, Anthony C Harrison, Axel Paehler, Christoph Funk, Andreas Gloge,[...]. J Pharmacol Exp Ther 2015
74
13

Metabotropic Glutamate Receptors in Central Nervous System Diseases.
Anna V Golubeva, Rachel D Moloney, Richard M O'Connor, Timothy G Dinan, John F Cryan. Curr Drug Targets 2016
28
17


Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study.
Daniel Rutrick, Dan J Stein, Ganesan Subramanian, Brian Smith, Maurizio Fava, Gregor Hasler, Jang-Ho Cha, Fabrizio Gasparini, Toni Donchev, Magdalena Ocwieja,[...]. Adv Ther 2017
23
21


Differential effects of chronic ethanol consumption and withdrawal on homer/glutamate receptor expression in subregions of the accumbens and amygdala of P rats.
Ilona Obara, Richard L Bell, Scott P Goulding, Cindy M Reyes, Lindsay A Larson, Alexis W Ary, William A Truitt, Karen K Szumlinski. Alcohol Clin Exp Res 2009
86
13


A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers.
Carolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, Harrison H Tran, Antonella Loche, Roberto Cacciaglia, Robert M Swift, Lorenzo Leggio. Eur J Pharm Sci 2017
15
33


Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors.
Gabriel Nowak, Lucyna Pomierny-Chamioło, Agata Siwek, Ewa Niedzielska, Bartosz Pomierny, Agnieszka Pałucha-Poniewiera, Andrzej Pilc. Neuropharmacology 2014
13
30

Cocaine withdrawal impairs metabotropic glutamate receptor-dependent long-term depression in the nucleus accumbens.
Chiung-Chun Huang, Che-Ming Yeh, Mei-Ying Wu, Alice Y W Chang, Julie Y H Chan, Samuel H H Chan, Kuei-Sen Hsu. J Neurosci 2011
54
11

Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder.
Funda Akkus, Sylvia Terbeck, Simon M Ametamey, Michael Rufer, Valerie Treyer, Cyrill Burger, Anass Johayem, Baltazar Gomez Mancilla, Judit Sovago, Alfred Buck,[...]. Int J Neuropsychopharmacol 2014
40
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.